March 22, 2010
The UC Neuroscience Institute s Functional Neuroscience Center, a center devoted to people who have diseases and disorders related to hearing, swallowing, voice, taste and smell, was recently designated one of a select number of national Auditory Brainstem Centers by Cochlear Corporation.
March 17, 2010
A technology developed by two UC professors is the impetus behind the new company OsteoDynamics, Inc.
March 2, 2010
Chiou-Fen Chuang, PhD, has been awarded a 2010 Sloan Research Fellowship from the Alfred P. Sloan Foundation to fund continuing neurodevelopment research.
March 1, 2010
Representatives from the University of Cincinnati, Jewish Health System, Inc. and Fort Hamilton Hospital and Healthcare Corporation announced today that they have signed a binding Memorandum of Understanding (MOU) resolving their respective interests in the Health Alliance.
March 4, 2010
Researchers at the University of Cincinnati have found that it is cost-effective to do CT scan screening of non-smoking women, ages 25-54, who come to the emergency room for the first time with a collapsed lung in order to diagnose and treat those with lymphangioleiomyomatosis, or LAM.
March 26, 2010
Identification of two new proteins in the Fanconi anemia DNA repair pathway may help explain genetic instability in people with Fanconi anemia and how otherwise healthy people are susceptible to cancer from environmentally triggered DNA damage.
March 31, 2010
A new clinical trial at UC Health University Hospital will help evaluate the effects of a cholesterol medication on patients at risk for heart disease.
March 15, 2010
The University of Cincinnati s Center for Clinical and Translational Science and Training has awarded five Community Health Program Grants to area agencies focused on improving health in the Greater Cincinnati region.
March 4, 2010
The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy the most common form of epilepsy in kids has established an evidence-based approach for initial drug therapy.
March 25, 2010
A study analysis by researchers at the University of Cincinnati confirms that the antibiotic rifaximin can reduce hospitalizations for patients and prevent the recurrence of a certain brain disorder caused by liver failure.